zoledronic acid has been researched along with Cancer of Salivary Gland in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Ge, XY; Jiang, Y; Li, SL; Yang, LQ; Yang, WW | 1 |
| Fujii, N; Ito, H; Nakabayashi, M; Ryoke, K; Shomori, K; Tamura, T | 1 |
2 other study(ies) available for zoledronic acid and Cancer of Salivary Gland
| Article | Year |
|---|---|
Reactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Blotting, Western; Bone Density Conservation Agents; Carcinoma, Adenoid Cystic; Cell Cycle; Cell Proliferation; Cisplatin; Diphosphonates; Drug Therapy, Combination; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Reactive Oxygen Species; Salivary Gland Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zoledronic Acid | 2014 |
Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Bone Density Conservation Agents; Carcinoma, Squamous Cell; Caspases; Cell Cycle; Cell Proliferation; Diphosphonates; Flow Cytometry; Humans; Imidazoles; Immunoenzyme Techniques; Mouth Neoplasms; Salivary Gland Neoplasms; Tumor Cells, Cultured; Zoledronic Acid | 2011 |